4//SEC Filing
SYNTA PHARMACEUTICALS CORP 4
Accession 0001179110-15-014555
$MDGLCIK 0001157601operating
Filed
Nov 4, 7:00 PM ET
Accepted
Nov 5, 6:40 PM ET
Size
5.1 KB
Accession
0001179110-15-014555
Insider Transaction Report
Form 4
Morenstein Scott D
Director
Transactions
- Award
Non-Employee Director Stock Option (Right to Buy)
2015-11-03+40,000→ 40,000 totalExercise: $0.67Exp: 2025-11-03→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]1. The option vests as to 25% of the shares on November 3, 2016 and as to an additional 6.25% of the shares on the last day of each successive three-month period thereafter.
Documents
Issuer
SYNTA PHARMACEUTICALS CORP
CIK 0001157601
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001157601
Filing Metadata
- Form type
- 4
- Filed
- Nov 4, 7:00 PM ET
- Accepted
- Nov 5, 6:40 PM ET
- Size
- 5.1 KB